Alpha Paradigm Partners’s Gilead Sciences GILD Stock Holding History

Alpha Paradigm Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$128K	Sell	1,491 -1,858	-55%	-$147K	0.05%	356
2022 Q3	$207K	Sell	3,349 -4,466	-57%	-$282K	0.09%	290
2022 Q2	$483K	Buy	7,815 +5,101	+188%	+$316K	0.2%	184
2022 Q1	$161K	Buy	+2,714	New	+$173K	0.06%	376
2021 Q2	–	Sell	-10,293	Closed	-$665K	–	589
2021 Q1	$665K	Sell	10,293 -2,852	-22%	-$184K	0.26%	121
2020 Q4	$766K	Buy	+13,145	New	+$793K	0.27%	96

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpha Paradigm Partners's GILD Position: Q4 2022 in Review

Alpha Paradigm Partners reduced its Gilead Sciences (GILD) stake by 55% in Q4 2022, selling an estimated $147K and leaving 1,491 shares worth $128K. The position accounts for 0.05% of the portfolio, ranked #356.

Alpha Paradigm Partners first reported a position in GILD in Q4 2020 and has held it in 6 quarters since. The position peaked at $766K in Q4 2020. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

Alpha Paradigm Partners held 1,491 shares of Gilead Sciences worth $128K as of Q4 2022.
Alpha Paradigm Partners sold 1,858 Gilead Sciences shares in Q4 2022, an estimated $147K.
Gilead Sciences made up 0.05% of Alpha Paradigm Partners's portfolio in Q4 2022, its #356 holding.
Alpha Paradigm Partners first reported a position in Gilead Sciences in Q4 2020 and has held it in 6 quarters since.
Alpha Paradigm Partners's Gilead Sciences position peaked at $766K in Q4 2020.
1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.